mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |